Company page

Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc. is a public company traded under the ticker LYEL in the American market. The company has a market capitalization of approximately $309.5 million. Lyell focuses on developing innovative immunotherapies for cancer treatment.